BBIO vs TTWO · rev $438.2M vs rev $6.66B
BridgeBio Pharma Inc (BBIO) versus Take-Two Interactive Software Inc (TTWO) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Take-Two Interactive Software Inc (TTWO) is a electronic gaming & multimedia company listed on NASDAQ.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
Latest reported TTWO revenue for 2026-03-31 was $6.66B. Net income was -$298.2M. Revenue was up 18.2% from 2025-03-31 to 2026-03-31. TTWO currently screens at market cap $42.34B.
BBIO currently screens at market cap $13.24B. TTWO currently screens at market cap $42.34B.
Not investment advice. Open the BBIO and TTWO stock pages for the full models.
Not investment advice.